IRS1 and Alzheimer disease: Furthermore, IRS-1 phospho-species achieved remarkable classification accuracy for AD patients vs. controls, and in a separate smaller cohort were already abnormal up to 10 years before clinical onset of AD (Kapogiannis et al., 2015).